The Asia Pacific Retinal Imaging Devices Market would witness market growth of 7.1% CAGR during the forecast period (2019-2025).
Optical coherence tomography (OCT) is equivalent to a histopathological portion of tissue. One can examine individual retinal cell layers and pathological lesions within them. OCT detects a subtle pathology that often goes overlooked during a clinical exam. An OCT device is used on an undilated pupil. Despite the density of cataracts, modern OCT machines can capture images of good quality. The recent addition of OCT angiography allows for dyeless visualization in the macula of retinal vessels.
In the end-use segment, the ambulatory surgery centers (ASCs) sub-segment has been anticipated to grow at the highest growth rate over the forecast period. The growth of the segment is expected to be driven by effective reimbursement policies by Medicare for vitreoretinal surgery in these centers. Hospitals retained the largest market share of retinal imaging products in 2018 due to the high demand for technologically advanced solutions.
Among middle-income countries, retinal disorders have been regarded as the critical causes behind the massive state of blindness across the world. In a recent rapid assessment of avoidable blindness plus diabetic retinopathy (RAAB plus DR) study in Western India, posterior segment disorders (PSD) accounted for nearly 39% of blindness next to cataract (45%). The major retinal diseases of public health significance are retinopathy of prematurity (ROP), diabetic retinopathy (DR), and age-related macular degeneration (ARMD).
Based on Type, the market is segmented into Fundus Camera, Fluorescein Angiography and OCT (Optical Coherence Tomography). Based on End Use, the market is segmented into Hospitals, Ophthalmic Centers, ASCs (Ambulatory Surgery Centers) and Other End Use. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Australia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Topcon Corporation, Carl Zeiss AG, Olympus Corporation, Robert Bosch GmbH (Bosch Healthcare), Revenio Group Oyj (CenterVue SpA), Nikon Corporation (Optos PLC), Optomed PLC, Epipole Ltd., Nidek Co., Ltd., and Eyenuk, Inc.
Scope of the Study
- Fundus Camera
- Fluorescein Angiography
- OCT (Optical Coherence Tomography)
By End Use
- Ophthalmic Centers
- ASCs (Ambulatory Surgery Centers)
- Other End Use
- South Korea
- Rest of Asia Pacific
- Topcon Corporation
- Carl Zeiss AG
- Olympus Corporation
- Robert Bosch GmbH (Bosch Healthcare)
- Revenio Group Oyj (CenterVue SpA)
- Nikon Corporation (Optos PLC)
- Optomed PLC
- Epipole Ltd.
- Nidek Co., Ltd.
- Eyenuk, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free